AVI BioPharma and US Department of Defense Successfully Complete Rapid …

This exercise centered around the dengue virus, a potentially fatal pathogen that infects up to 100 million people globally each year. In 2009, AVI successfully completed its first formal TMT rapid response exercise against the pandemic H1N1 influenza …
See all stories on this topic »